Hemodialysis Without Anticoagulation in Intensive Care Unit
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00242398|
Recruitment Status : Unknown
Verified October 2007 by Centre Hospitalier Départemental.
Recruitment status was: Recruiting
First Posted : October 20, 2005
Last Update Posted : October 3, 2007
|Condition or disease||Intervention/treatment||Phase|
|Kidney Failure Critically Ill Hemorrhage||Device: AN69 ST||Phase 3|
Hemodialysis in patients who are at high risk of bleeding complications represents a challenge of balancing the needs for establishment of an adequately functioning extracorporeal circuit for dialytic therapy with the requirement of not exacerbating existing bleeding or precipitating bleeding in predisposed subjects.
Several methods of nonheparin dialysis have been used. The method most commonly used to effect such treatment is "saline flushing": saline boluses are delivred at frequent intervals. This method is far from optimal for several reasons, including failure to maintain a patent circuit in significant proportion of patients, an added logistic burden on dialysis nurses. An alternative method of avoiding systemic heparinization is priming the dialysis membrane with heparin before hemodialysis. The method is based on fact that AN69ST (Nephral 400ST , Hospal, France) dialysis membrane have a high affinity for binding heparin, and that the bound heparin exerts a localized antithrombotic effect without systemic spillover.
Comparison: heparin free hemodialysis with saline flushes compared heparin free hemodialysis with Nephral 400ST.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||Heparin Free Hemodialysis for Patients With Bleeding High Risk in ICU. Randomized Study: Heparin Free Dialysis With Intermittent Saline Flushes Versus Heparin Free Dialysis With Nephral 400ST (AN69ST, Hospal, France)|
|Study Start Date :||October 2005|
|Estimated Study Completion Date :||April 2008|
- Early stop dialysis treatment for rapid and persistent elevations in venous extracorporeal pressure secondary to extracorporeal thrombosis. [ Time Frame: at the end of the dialysis treatement ]
- Blood lost associated with extracorporeal thrombosis or active bleeding [ Time Frame: At the end of the dialysis treatment ]
- Necessary time of nurse's work [ Time Frame: During the dialysis treatment ]
- Weight lost patients during dialysis treatment [ Time Frame: At the end of dialysis treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00242398
|Contact: Laurent Martin-Lefèvre, MD||33(0)firstname.lastname@example.org|
|La Roche sur Yon, France, 85925|
|Contact: Laurent Martin-Lefevre|
|Principal Investigator: Laurent Martin-Lefèvre|
|Principal Investigator:||Laurent Martin-Lefèvre|